Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of three different doses of sufentanil on blood pressure and heart rate after laryngoscopy and intubation
IRCT20190721044298N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sufentanil (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Change in blood pressure after laryngoscopy and intubation and Change in heart rate after laryngoscopy and intubation. Started Apr 2019; status: completed.
02
Drugs
sufentanil
Beyond the preview
Go deeper on IRCT20190721044298N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190721044298N1.